Published in Women's Health Weekly, January 18th, 1999
It is the first report to assess the late effects of AZT exposure in healthy HIV uninfected children born to mothers who took the drug to prevent transmitting HIV to their offspring.
The study, sponsored by the Pediatric AIDS Clinical Trials Group (PACTG) and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly